Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease

Prion

Volumn 8, Issue 1, 2014, Pages 143-153

  Harischandra, Dilshan S ^a   Kondru, Naveen ^a   Martin, Dustin P ^a   Kanthasamy, Arthi ^a   Jin, Huajun ^a   Anantharam, Vellareddy ^a   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Neurodegeneration; Phosphorylation; Protein kinase C ; Proteolytic activation; RML scrapie

Indexed keywords

MESSENGER RNA; PROTEIN KINASE C DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRION; PRION DISEASE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; SCRAPIE; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CEREBELLUM; ENZYME ACTIVATION; ENZYMOLOGY; IN VITRO STUDY; METABOLISM; PATHOLOGY;

ANIMALS; CEREBELLUM; ENZYME ACTIVATION; IN VITRO TECHNIQUES; MICE; MICE, INBRED C57BL; PRION DISEASES; PROTEIN KINASE C-DELTA; PROTEOLYSIS;

EID: 84896917248     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.28369     Document Type: Article

References (63)

1. Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439- 77; PMID:18558863; http://dx.doi.org/10.1146/ annurev.neuro.31.060407.125620
2. Martin DP, Anantharam V, Jin H, Witte T, Houk R, Kanthasamy A, Kanthasamy AG. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology 2011; 32:554-62; PMID:21871919; http://dx.doi.org/10.1016/j.neuro.2011.07.008
3. Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 1996; 21:482- 7; PMID:9009832; http://dx.doi.org/10.1016/ S0968-0004(96)10063-3
4. Anantharam V, Kanthasamy A, Choi CJ, Martin DP, Latchoumycandane C, Richt JA, Kanthasamy AG. Opposing roles of prion protein in oxidative stressand ER stress-induced apoptotic signaling. Free Radic Biol Med 2008; 45:1530-41; PMID:18835352; http:// dx.doi.org/10.1016/j.freeradbiomed.2008.08.028
5. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7; PMID:8035877; http://dx.doi. org/10.1038/370295a0
6. Kanthasamy AG, Choi C, Jin H, Harischandra DS, Anantharam V, Kanthasamy A. Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation. Toxicol Lett 2012; 214:288-95; PMID:22995398; http://dx.doi. org/10.1016/j.toxlet.2012.09.008
7. Choi CJ, Kanthasamy A, Anantharam V, Kanthasamy AG. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 2006; 27:777-87; PMID:16860868; http://dx.doi.org/10.1016/j. neuro.2006.06.004
8. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti- PrP antibodies. Proc Natl Acad Sci U S A 1993; 90:10608-12; PMID:7902565; http://dx.doi. org/10.1073/pnas.90.22. 10608
9. Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 2000; 7:270- 3; PMID:10964599; http://dx.doi.org/10.1006/ nbdi.2000.0290
10. Kim JI, Choi SI, Kim NH, Jin JK, Choi EK, Carp RI, Kim YS. Oxidative stress and neurodegeneration in prion diseases. Ann N Y Acad Sci 2001; 928:182-6; PMID:11795509; http://dx.doi. org/10.1111/j.1749-6632.2001.tb05648.x
11. Brown DR. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol 2005; 43:229-43; PMID:16416388
12. Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, Rana A. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. Neurotoxicology 2010; 31:555-61; PMID:20005250; http://dx.doi.org/10. 1016/j.neuro.2009.12.003
13. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 2005; 280:28721-30; PMID:15961393; http:// dx.doi.org/10.1074/jbc.M501092200
14. Lin M, Chandramani-Shivalingappa P, Jin H, Ghosh A, Anantharam V, Ali S, Kanthasamy AG, Kanthasamy A. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience 2012; 210:308- 32; PMID:22445524; http://dx.doi.org/10.1016/j. neuroscience.2012.03.004
15. Saminathan H, Asaithambi A, Anantharam V, Kanthasamy AG, Kanthasamy A. Environmental neurotoxic pesticide dieldrin activates a non receptor tyrosine kinase to promote PKCβ-mediated dopaminergic apoptosis in a dopaminergic neuronal cell model. Neurotoxicology 2011; 32:567- 77; PMID:21801747; http://dx.doi.org/10.1016/j. neuro.2011.06.009
16. Mewes A, Franke H, Singer D. Organotypic brain slice cultures of adult transgenic P301S mice-a model for tauopathy studies. PLoS One 2012; 7:e45017; PMID:22984603; http://dx.doi.org/10.1371/journal. pone.0045017
17. Cho S, Wood A, Bowlby MR. Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol 2007; 5:19-33; PMID:18615151; http://dx.doi. org/10.2174/ 157015907780077105
18. Falsig J, Julius C, Margalith I, Schwarz P, Heppner FL, Aguzzi A. A versatile prion replication assay in organotypic brain slices. Nat Neurosci 2008; 11:109- 17; PMID:18066056; http://dx.doi.org/10.1038/ nn2028
19. Falsig J, Sonati T, Herrmann US, Saban D, Li B, Arroyo K, Ballmer B, Liberski PP, Aguzzi A. Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog 2012; 8:e1002985; PMID:23133383; http://dx.doi. org/10.1371/journal.ppat.1002985
20. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-11; PMID:6815801; http:// dx.doi.org/10.1126/science.6815801
21. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008; 3:e3872; PMID:19060956; http://dx.doi. org/10.1371/journal.pone.0003872
22. Sigurdson CJ, Joshi-Barr S, Bett C, Winson O, Manco G, Schwarz P, Rülicke T, Nilsson KP, Margalith I, Raeber A, et al. Spongiform encephalopathy in transgenic mice expressing a point mutation in the ?2-?2 loop of the prion protein. J Neurosci 2011; 31:13840-7; PMID:21957246; http://dx.doi. org/10.1523/JNEUROSCI.3504-11.2011
23. Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG. Transcriptional regulation of proapoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death. J Biol Chem 2011; 286:19840-59; PMID:21467032; http:// dx.doi.org/10.1074/jbc.M110.203687
24. Gordon R, Anantharam V, Kanthasamy AG, Kanthasamy A. Proteolytic activation of proapoptotic kinase protein kinase C? by tumor necrosis factor ? death receptor signaling in dopaminergic neurons during neuroinflammation. J Neuroinflammation 2012; 9:82; PMID:22540228; http://dx.doi. org/10.1186/1742- 2094-9-82
25. Kanthasamy AG, Kitazawa M, Kaul S, Yang Y, Lahiri DK, Anantharam V, Kanthasamy A. Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease. Ann N Y Acad Sci 2003; 1010:683-6; PMID:15033812; http://dx.doi.org/10.1196/ annals.1299.125
26. Pamplona R, Naudí A, Gavín R, Pastrana MA, Sajnani G, Ilieva EV, Del Río JA, Portero-Otín M, Ferrer I, Requena JR. Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease. Free Radic Biol Med 2008; 45:1159-66; PMID:18703134; http://dx.doi.org/10.1016/j. freeradbiomed.2008.07.009
27. Freixes M, Rodríguez A, Dalfó E, Ferrer I. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 2006; 27:1807-15; PMID:16310893; http://dx.doi. org/10.1016/j.neurobiolaging.2005.10.006
28. Yuan F, Yang L, Zhang Z, Wu W, Zhou X, Yin X, Zhao D. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases. J Mol Neurosci 2013; 51:219-24; PMID:23715697; http://dx.doi.org/10.1007/ s12031-013-0008-6
29. Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondriatargeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes. Biochim Biophys Acta 2013; PMID:24060637; http://dx.doi. org/10.1016/j.bbadis.2013.09.007
30. Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease. Toxicol Appl Pharmacol 2011; 256:314-23; PMID:21846476; http://dx.doi.org/10.1016/j.taap.2011.07.021
31. Li W, Mischak H, Yu JC, Wang LM, Mushinski JF, Heidaran MA, Pierce JH. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J Biol Chem 1994; 269:2349-52; PMID:7507923
32. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998; 281:2042- 5; PMID:9748166; http://dx.doi.org/10.1126/ science.281.5385.2042
33. Yang Q, Hashizume Y, Yoshida M, Wang Y. Neuropathological study of cerebellar degeneration in prion disease. Neuropathology 1999; 19:33-9; PMID:19519645; http://dx.doi. org/10.1046/j.1440-1789.1999.00212.x
34. Carimalo J, Cronier S, Petit G, Peyrin JM, Boukhtouche F, Arbez N, Lemaigre-Dubreuil Y, Brugg B, Miquel MC. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection. Eur J Neurosci 2005; 21:2311-9; PMID:15932590; http:// dx.doi.org/10.1111/j.1460-9568.2005.04080.x
35. Bourteele S, Oesterle K, Weinzierl AO, Paxian S, Riemann M, Schmid RM, Planz O. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol 2007; 9:2202-17; PMID:17573907; http://dx.doi.org/10.1111/j.1462-5822.2007.00950.x
36. Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006; 4:765-75; PMID:16980938; http:// dx.doi.org/10.1038/nrmicro1492
37. Bessen RA, Robinson CJ, Seelig DM, Watschke CP, Lowe D, Shearin H, Martinka S, Babcock AM. Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters. PLoS One 2011; 6:e28026; PMID:22174765; http://dx.doi.org/10.1371/journal. pone.0028026
38. Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO J 2008; 27:2557-66; PMID:18800058; http://dx.doi. org/10.1038/emboj.2008.181
39. Collins S, McLean CA, Masters CL. Gerstmann- Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001; 8:387-97; PMID:11535002; http:// dx.doi.org/10.1054/jocn.2001.0919
40. O'Shea M, Maytham EG, Linehan JM, Brandner S, Collinge J, Lloyd SE. Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics 2008; 180:559-66; PMID:18716327; http://dx.doi.org/10. 1534/ genetics.108.090894
41. Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J Pharmacol Exp Ther 2007; 322:913-22; PMID:17565007; http://dx.doi.org/10.1124/jpet.107.124669
42. Falsig J, Aguzzi A. The prion organotypic slice culture assay-POSCA. Nat Protoc 2008; 3:555- 62; PMID:18388937; http://dx.doi.org/10.1038/ nprot.2008.13
43. Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stressinduced apoptosis. Antioxid Redox Signal 2003; 5:609-20; PMID:14580317; http://dx.doi. org/10.1089/152308603770310275
44. Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG. β-Synuclein negatively regulates protein kinase C? expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 2011; 31:2035- 51; PMID:21307242; http://dx.doi.org/10. 1523/ JNEUROSCI.5634-10.2011
45. Sinclair L, Lewis V, Collins SJ, Haigh CL. Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection. Dis Model Mech 2013; 6:952-63; PMID:23580200; http:// dx.doi.org/10.1242/dmm.010678
46. Sonati T, Reimann RR, Falsig J, Baral PK, O'Connor T, Hornemann S, Yaganoglu S, Li B, Herrmann US, Wieland B, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 2013; 501:102-6; PMID:23903654; http:// dx.doi.org/10.1038/nature12402
47. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 2002; 132:831-9; PMID:12473183; http://dx.doi.org/10.1093/oxfordjournals. jbchem.a003294
48. Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 2002; 22:1738-51; PMID:11880503
49. Kitazawa M, Anantharam V, Kanthasamy AG. Dieldrin induces apoptosis by promoting caspase- 3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 2003; 119:945-64; PMID:12831855; http://dx.doi. org/10.1016/S0306-4522(03)00226-4
50. Reyland ME. Protein kinase Cdelta and apoptosis. Biochem Soc Trans 2007; 35:1001-4; PMID:17956263; http://dx.doi.org/10.1042/ BST0351001
51. Yun SW, Gerlach M, Riederer P, Klein MA. Oxidative stress in the brain at early preclinical stages of mouse scrapie. Exp Neurol 2006; 201:90- 8; PMID:16806186; http://dx.doi.org/10.1016/j. expneurol.2006.03.025
52. Merchenthaler I, Liposits Z, Reid JJ, Wetsel WC. Light and electron microscopic immunocytochemical localization of PKC delta immunoreactivity in the rat central nervous system. J Comp Neurol 1993; 336:378-99; PMID:8263228; http://dx.doi. org/10.1002/cne.903360306
53. Barmack NH, Qian Z, Yoshimura J. Regional and cellular distribution of protein kinase C in rat cerebellar Purkinje cells. J Comp Neurol 2000; 427:235-54; PMID:11054691; http://dx.doi.org/10.1002/1096-9861(20001113)427: 2<235::AID-CNE6>3.0.CO;2-6
54. Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry 2006; 77:1273-5; PMID:16835290; http://dx.doi.org/10.1136/ jnnp.2006.088930
55. Glatzel M, Stoeck K, Seeger H, Lührs T, Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol 2005; 62:545-52; PMID:15824251; http://dx.doi.org/10.1001/archneur.62.4.545
56. Deacon RM. Measuring the strength of mice. J Vis Exp 2013; PMID:23770643
57. Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 2008; 31:89-101; PMID:18502140; http:// dx.doi.org/10.1016/j.nbd.2008.03.011
58. Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp 2010; PMID:20495529; http://dx.doi.org/10.3791/1787
59. Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra DS, Qian Z, Rana A, Kanthasamy AG. The peptidylprolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem 2013; 288:21955-71; PMID:23754278; http://dx.doi. org/10.1074/jbc.M112.444224
60. Kanthasamy AG, Anantharam V, Zhang D, Latchoumycandane C, Jin H, Kaul S, Kanthasamy A. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radic Biol Med 2006; 41:1578-89; PMID:17045926; http://dx.doi.org/10.1016/j. freeradbiomed.2006.08.016
61. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002; 416:865-9; PMID:11976687; http://dx.doi.org/10.1038/416865a
62. Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53:325-35; PMID:17270731; http://dx.doi. org/10.1016/j. neuron.2007.01.005
63. Guenther K, Deacon RM, Perry VH, Rawlins JN. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 2001; 14:401-9; PMID:11553290; http://dx.doi. org/10.1046/j.0953-816x.2001.01645.x